Christopher Stanley Email & Phone Number

Barrow, Manchester, Cambridge, Guildford, London Paddington And St Pancras, 4 Mobile Laboratories

Taking the Chief Scientist consulting role to provide oversight of the science aspects of the routine testing laboratory. Implementing the LAMPWorx (high throughput molecular testing) and ProteinWorx (high throughput laboratory-based lateral flow) protocols; providing high accuracy COVID testing to >50 corporate clients for workforce screening. Also.

Carlisle, Barrow, Manchester, Guildford, Cambridge, London

In response to the need for large scale COVID-19 testing in the UK Circular1 Health was founded to provide high throughput laboratory testing services in the private sector. The aim was to implement a novel ultra-high accuracy testing programme for SARS-CoV-2 using the best genomic testing technologies available from the IVD industry. The testing algorithm.

Liverpool, United Kingdom

Update April 2021: Achieved successful exit to become part of a larger group focussing on therapeutics and diagnostics in the Alzheimer's field - exploiting CynapseDx' expertise in blood oligomeric protein biomarkers and continuing development of the company's novel therapeutic apheresis treatment for neurodegenerative diseases.(The new name for CellCap.

London, England Metropolitan Area

Returned to the CEO role at Microsens in 2019 to lead the fund raising programme for our TB and sepsis products. Somewhat overtaken by events in March 2020; the patient-side TB test was reconfigured as a SARS-CoV-2 molecular test in less than a week by our co-founder and CSO Dr Stuart Wilson. This assay is based on our proprietary RapiPREP RNA sample.

Exeter, United Kingdom

Professor Toby Mottram founded Milkalyser to commercialise an automated progesterone analysis system to revolutionise dairy cow fertility management. Milkalyser has recently received investment from the Mercia Fund in the UK. Having developed one of the first on-farm manual, microplate-based progesterone assays in the early 1980s I'm delighted to be back.

London, United Kingdom

Co-founder, developing rapid rapid microbiology products using novel sample preparation techniques. Focus on TB and other diseases in developing country markets.

Liverpool, United Kingdom

ProKyma Technologies Ltd (www.prokyma.com) was founded in 2006 as a spin out from dstl, Porton Down, UK. In 2012 ProKyma, in partnership with the University of Liverpool’s Centre for Tissue Engineering and the Pancreatic Cancer Unit located at the Royal Liverpool University Hospital, was awarded a three year GBP 500,000 i4i (Invention for Innovation) grant.

Liverpool, United Kingdom

CellCap Technologies Ltd was founded in March 2012 to acquire IP assets in the cell purification field. CellCap maintains an interest in stem cell analysis and purification from lipoaspirates. However, more recently the company has changed focus and is now developing in vitro diagnostic tests in the neurological disease field. The aim is to develop.

London, United Kingdom

One of the Microsens companies. ISEAO developed the ligase mediated amplification technology, LIMA, one of the most sensitive methods available for detection of all bacteria, with the ability to reliably detect 1 to 10 bacterial cells.

London, United Kingdom

Microsens Medtech has applied proprietary sample preparation technology to the detection of Mycobacterium tuberculosis (TB). The TB-Beads system can be used to easily and rapidly isolate TB from patient’s samples such as sputum and tissue biopsies. The Microsens range of TB products provide all the key components required for the enhanced diagnosis of TB.

London, United Kingdom

Microsens Biotechnologies (www.microsens.co.uk), based in London, UK is involved in research and development, technology licensing and manufacturing in the clinical, food safety and veterinary in vitro diagnostic (IVD) markets. The company's focus is the field of protein aggregation diseases, such as the prion diseases BSE, vCJD and BSE; as well as.

Copenhagen Area, Denmark

Large-scale protein purification based on novel expanded bed chromatography. Applications in industrial protein extraction (food and feed) and biopharmaceutical production (monoclonal antibody, plasma fractionation. Pharma applications acquired by DSM Biologics in January 2010. http://www.dsm.com/en_US/html/dpp/home_dpp.htm

Cambridge, United Kingdom

St Ives, Cambridgeshire

Bury, Lancashire

Cambridge, United Kingdom

Cambridge, United Kingdom

Phd, Enzymology

Bsc, Biochemistry